YÜKSEK RAKIMDA YAŞAYAN BEHÇET HASTALARINDA HEMATOKRİT YÜKSEKLİĞİNİN VASKÜLER TUTULUMA ETKİSİ

AMAÇ: Behçet hastalığı tanısıyla izlenen hastalarda denizseviyesinden 1890 m de yaşamanın vasküler tutulum ve trombüs ileilişkisi incelendi.GEREÇ VE YÖNTEM: Yüksek rakımda yaşamakta olan (ortalama1890 metre) bir eğitim araştırma hastanesinde takip edilen Behçethastalığı tanısı konulmuş olan hastalar ile 890 metrede yaşayanBehçet hastalarının vasküler patoloji ve trombüs açısından klinik vedemografik verileri retrospektif olarak karşılaştırıldı.BULGULAR: İki grubun yaş ortalaması ve cinsiyet dağılımıaçısından istatiksel olarak anlamlı bir fark yoktu. Vasküler tutulum vetromboembolik olaylar açısından her iki grupta benzer tutulum gözlendi.SONUÇ: 1890 metre yükseklikte yaşayanlarda, yüksek rakımnedeniyle oluşmuş olan hematokrit yüksekliği Behçet hastalarındavasküler tutulum ve vaskülite bağlı trombüs için ilave bir riskoluşturmamaktadır.

THE EFFECT OF HEMATOCRIT ELEVATION ON VASCULAR INVOLVEMENT IN BEHÇET PATIENTS LIVING AT HIGH ALTITUDE

PURPOSE: We investigated the relationship between vascular involvement / thrombotic events and living at high altitude (1890 m above sea level) in patients with Behçet's disease. MATERIAL AND METHODS: The frequency of vascular involvement / thrombotic events in Behçet patients living at high (1890 m) and lower (890 m) altitudes was compared retrospectively. RESULTS: There was no statistically significant difference between the two groups in terms of mean age and gender distribution. Similar frequency of vascular involvement and thromboembolic events was observed in both groups. CONCLUSION: In patients with Behcet’s disease, elevated hematocrit levels due to living at high altitude do not pose an additional risk for vascular involvement and thrombotic events.

PDF

___

1.)Hatemi G, Yazici Y, Yazici H. Behcet’s syndrome. Rheum Dis Clin North Am. 2013;39:245-261
2.)Seyahi EK, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center Medicine, 2003;82:60-76
3.)Davatchi F, Shahram F, Chams-Davatchi C et al. Behcet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010 Oct;13(4):367-73
4.)Chen Y, Cai JF, Lin CH, Guan JL. Demography of vascular Behcet's disease with different gender and age: an investigation with 166 Chinese patients. Orphanet J Rare Dis. 2019 Apr 29;14:88
5.)Saadoun D, Wechsler B, Desseaux K, et al. Mortality in Behçet's disease. Arthritis Rheum. 2010 Sep;62:2806-12
6.)Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. Behçet's syndrome: a critical digest of the 2013-2014 literature. Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S112-22
7.)Yazıcı H, Seyahi E. Behçet syndrome: the vascular cluster. Turk J Med Sci. 2016 Nov 17;46(5):1277-1280
8.)Bahbahani H, Aljenaee K, Bella A. Polycythemia vera presenting as acute myocardial infarction: An unusual presentation. J Saudi Heart Assoc. 2015 Jan;27(1):57-60
9.)Lizarraga WA, Dalia S, Reinert SE, Schiffman FJ. Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis. 2010 Jul;21(5):431-5
10.)Fujimaki T, Matsutani M, Asai A, Kohno T, Koike M. Cerebral venous thrombosis due to high-altitude polycythemia: case report. J Neurosurg. 1986; 64:148–150
11.)Alibaz-Oner F, Karadeniz A, Yilmaz S, et al. Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore). 2015 Feb;94(6):494
12.)Saito S, Tanaka SK. A case of cerebral sinus thrombosis developed during a high-altitude expedition to Gasherbrum I. Wilderness Environ Med. 2003 Winter;14(4):226-30
13.)Jha SK, Anand AC, Sharma V, Kumar N, Adya CM. Stroke at high altitude: Indian experience. High Alt Med Biol. 2002; 3: 21–27
14.)Dickinson J, Heath D, Gosney J, Williams D. Altitude-related deaths in seven trekkers in the Himalayas. Thorax. 1983; 38: 646–656
15.)Hull CM, Rajendran D, Barnes AF. Deep Vein Thrombosis and Pulmonary Embolism in a Mountain Guide: Awareness, Diagnostic Challenges, and Management Considerations at Altitude Wilderness Environ Med. 2016 Mar;27(1):100-6
16.)Gupta N, Ashraf MZ. Exposure to high altitude: a risk factor for venous thromboembolism? Semin Thromb Hemost. 2012 Mar;38(2):156-63
17.)Alibaz-Oner F, Direskeneli H. Management of vascular Behçet's disease. Int J Rheum Dis. 2019 Jan;22 Suppl 1:105-108
18.)Hirsjarvi E, Vihavainen M, Koikkalainen K. Polycythemia in Chronic Respiratory Anoxia. Ann Acad Sci Fenn A. 1964;106:1-13
19.)Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers. Med J Aust. 1975 May 17;1(20):617-20
20.)Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med. 2018 May 24; 378(21): 2010-2021
21.)Dautaj A, Krasi G, Bushati V, et al. Hereditary thrombophilia. Acta Biomed. 2019 Sep 30;90(10-S):44-46